ADL-R3 20mg

ADL-R3 20mg (Retatrutide) is a synthetic peptide with agonist activity at glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. It is offered for laboratory investigation of multi-receptor metabolic signaling, receptor-response comparisons, and pathways associated with glucose regulation, lipid metabolism, and energy balance. Nominal content: 20mg per vial. Batch-specific third-party COA documentation is pending; purity, identity, and measured net content are not yet independently verified for this lot. For laboratory research use only. Not for human or veterinary use. No administration or dosing guidance is provided.